1. Ben Abdallah M (1997) Epidemiologie des cancers en Tunisie. Registre de l’institut Salah Azaez.
2. Henle G, Henle W (1976) Epstein–Barr-virus specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17:1–7.
3. Raab-traub N (1992) Epstein–Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol 3:297–307.
4. Zhang M, Liu L, Cheng L et al (2003) Express of plasma ROS, SOD and GSH-PX in patients with nasopharyngeal carcinoma. Lin Chuang Er Bi Yan Hou Ke Za Zhi 17:650–651.
5. Su Y, Xia YF, Yang H.L et al (2003) Changes of superoxide dismutase (SOD) and metallothionien (MT) before, during, and after radiotherapy for nasopharyngeal carcinoma and their significance. Ai Zheng 22:629–633.